First OTC drug approved for women with overactive bladder

(HealthDay)—The drug Oxytrol has been approved by the U.S. Food and Drug Administration as the first over-the-counter treatment for women 18 and older with overactive bladder.

is characterized by symptoms including leakage, frequent urination and feeling the sudden and urgent need to urinate. The condition affects some 33 million Americans, mostly older women.

Oxytrol contains oxybutynin, among a class of drugs called anticholinergics that are designed to relax the . Oxytrol is a patch applied to the skin every four days, the FDA said in a news release.

The drug will remain available for adult men by prescription only, the agency said.

Side effects reported during clinical testing included skin irritation at the patch site, dry mouth and constipation.

Oxytrol for Women is marketed by Merck, based in Whitehouse Station, N.J.

More information: To learn more about overactive bladder, visit the U.S. Department of Health and Human Services.

Related Stories

Myrbetriq approved for overactive bladder

date Jun 28, 2012

(HealthDay) -- Myrbetriq (mirabegron) has been approved to treat adults with overactive bladder, a condition affecting some 33 million Americans, the U.S. Food and Drug Administration said Thursday in a news release.

Recommended for you

Solid, heat-resistant vaccine to ease immunisation processes

date Apr 30, 2015

EU researchers have set out to substitute liquid and freeze-dried vaccines for new, solid state candidates. If successful, the research will enable the large scale production of new virosome-based vaccines with increased ...

Screening for bacteriuria in pregnant women: Benefit unclear

date Apr 30, 2015

Due to a lack of suitable studies, no conclusions can be drawn on the patient-relevant benefit or harm of screening for asymptomatic bacteriuria (ASB) in pregnant women. The benefit of antibiotic treatment of ASB following ...

First generic Abilify approved

date Apr 30, 2015

(HealthDay)—The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.